Allergy Diagnostics Market worth $10.77 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 17, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Allergy Diagnostics Market is projected to grow from about USD 6.80 billion in 2026 to USD 10.77 billion by 2031, at a CAGR of 9.6%.

https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Browse 250 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on ‘Allergy Diagnostic Market- Global Forecast to 2031’

Allergy Diagnostic Market Size & Forecast:

• Market Size Available for Years: 2025-2031
• 2026 Market Size: USD 6.80 billion
• 2031 Projected Market Size: USD 10.77 billion
• CAGR (2026-2031): 9.6%

Allergy Diagnostic Market Trends & Insights:

• The consumables segment led the market, accounting for a share of 60.0% in 2025.
• In vivo test type dominated the market, with a share of 55.0% in 2025.
• Asia Pacific is expected to register the highest CAGR of 10.4% during the forecast period.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

The rise in allergic disorders worldwide has been remarkable over the last few years. These disorders include allergic rhinitis, asthma, atopic dermatitis, and food allergies. The rise of allergies worldwide has been driven by a combination of genetic susceptibility and environmental factors, including increased urbanization, pollution, and changing lifestyle patterns. As a result of people having symptoms such as sneezing, itching, wheezing, and digestive discomfort, the need for precise and timely diagnosis becomes critical. Allergy diagnostics are useful for distinguishing between allergens, thus allowing targeted treatment or only symptomatic relief. For instance, detection of IgE sensitivity to certain pollens or foods enables doctors to advise avoidance, immunotherapy, or personalized pharmacological treatments. In areas where pollen concentrations are high, e.g., some parts of North America and Europe, the fraction of people suffering from seasonal allergies is very high; thus, the local authorities are encouraged to provide screening and management for the whole population. Likewise, recognition of food allergies in kids is on the rise, so pediatric departments are emphasizing diagnostic tests to avoid prescribing long-term avoidance diets that may cause nutritional deficiencies.

By Product & Service, bipolar electrosurgical instruments accounted for the largest share of the electrosurgical instruments market in 2024.

The inherent characteristics of allergy diagnostic consumables significantly contribute to their high market share. Most consumables, including reagents, allergen extracts, test strips, and assay cartridges, are designed for single use to ensure diagnostic accuracy and prevent cross-contamination. In addition, many reagents have limited shelf lives and require controlled storage conditions, necessitating frequent replenishment by laboratories. These factors create a steady replacement cycle that drives recurring sales volumes. Unlike instruments, which can be used for several years, consumables generate continuous purchasing requirements regardless of testing volume fluctuations. This structural dependency on consumables for daily laboratory operations ensures predictable revenue streams for manufacturers and reinforces their dominant contribution to the overall allergy diagnostic market.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

By Test Type, in vitro test type accounted for the majority of market share in 2025.

In vivo testing allows clinicians to assess patient sensitivity to multiple allergens simultaneously during a single clinical visit. Standard skin-prick panels can include dozens of allergens, such as pollens, dust mites, molds, animal dander, and foods. This broad coverage improves diagnostic efficiency and reduces the need for repeat testing. The ability to rapidly screen multiple allergens is particularly valuable in patients with complex or unclear allergy histories. This diagnostic comprehensiveness drives clinician preference and increases test volumes, reinforcing the strong market position of in vivo tests.

Asia Pacific to exhibit the highest growth rate in the allergy diagnostic market during the forecast period.

Asia Pacific is witnessing a sharp rise in allergic conditions such as allergic rhinitis, asthma, food allergies, and atopic dermatitis. Rapid urbanization, changing dietary habits, increased exposure to environmental pollutants, and sedentary lifestyles are key contributors. Large population bases in countries such as China and India amplify the absolute number of allergy patients, creating a substantial unmet diagnostic need. As allergy symptoms often overlap with other respiratory or dermatological conditions, demand for confirmatory diagnostic testing is increasing, directly supporting strong growth in allergy diagnostics across the region.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=232871701

Top Companies in Allergy Diagnostics Market:

The Top Companies in Allergy Diagnostics Market include Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Minaris Medical America, Inc. (US), Omega Diagnostics Group Plc (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (Germany), HollisterStier Allergy (US), Eurofins Scientific (Luxembourg), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Erba Group (UK), Alcit India Pvt. Ltd. (India), Biopanda Reagents (UK), Bioside S.r.l. (Italy), Creative Diagnostic Medicare Pvt. Ltd. (India), DST Diagnostische Systeme & Technologien GmbH (Germany), and Dr. Fooke Laboratorien GmbH (Germany).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

In Vitro Diagnostics Market

– Global Forecast to 2030

IVD Quality Control Market

– Global Forecast to 2030

Immunoassay Market

– Global Forecast to 2030

Point of Care Diagnostics Market

– Global Forecast to 2029

Vaccines Market

– Global Forecast to 2030

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/allergy-diagnostics-market-worth-10-77-billion-by-2031–marketsandmarkets-302689322.html